Search

Day One Biopharmaceuticals Inc

Chiusa

SettoreSettore sanitario

0

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

Massimo

Metriche Chiave

By Trading Economics

Entrata

-21M

Vendite

54M

Margine di Profitto

-39.611

Dipendenti

178

EBITDA

-26M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

-3.62% downside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

2.2B

Apertura precedente

0

Chiusura precedente

0

Day One Biopharmaceuticals Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

23 ott 2026, 23:56 UTC

News

Sherwin-Williams Co declared a quarterly dividend of $0.80 per share, with shares advancing modestly higher in after-market trading.

23 ott 2026, 23:56 UTC

News

Hershey Co shares advanced in after-market trading as analysts expect increased earnings and revenue for the September 2026 quarter, driven by brand spending and new product launches.

23 ott 2026, 23:51 UTC

News

Jefferies maintains Hold rating on RingCentral and raises price target to $75, reflecting ongoing evaluations of the company's market position and growth potential.

23 ott 2026, 23:51 UTC

News

Wix.com Ltd shares are trading lower in after-market hours following a partnership announcement with K Health to integrate its clinical AI assistant into web technology.

23 ott 2026, 23:51 UTC

News

Jefferies upgraded MSC Industrial Direct Co to Buy and raised its price target to $135, contributing to the stock's increase in after-market trading.

23 ott 2026, 23:41 UTC

News

DA Davidson maintained a Neutral rating on Pool Corp and lowered its price target to $200, contributing to the stock's decline in after-market hours.

23 ott 2026, 23:41 UTC

Social Media
News

CME Group Inc is trading modestly higher in after-market hours, following a report of $326.7 billion in Bitcoin derivatives trading volume for Q3.

23 ott 2026, 23:21 UTC

News

Pomerantz LLP has filed a class action lawsuit against Papa John's International Inc. over alleged securities fraud and unlawful business practices.

23 ott 2026, 23:11 UTC

News

Carriage Services Inc. plans to release its third-quarter earnings on November 4, 2026, followed by a conference call on November 5.

23 ott 2026, 23:11 UTC

News

Telsey Advisory Group maintains Market Perform rating on Deckers Outdoor Corp and lowers price target to $90.

23 ott 2026, 23:06 UTC

News

Estee Lauder Companies Inc. is trading lower in after-market hours.

23 ott 2026, 23:06 UTC

News

Dow Inc. reported third-quarter 2026 sales of $11.27 billion and net income of $458 million, with shares modestly lower in after-market trading.

23 ott 2026, 23:06 UTC

News

Citigroup restricts third-party AI agents from accessing its banking platforms, addressing security concerns shared by major banks like Wells Fargo and JPMorgan Chase.

23 ott 2026, 23:06 UTC

News

BlackRock Inc trades roughly flat since Friday's close.

23 ott 2026, 23:06 UTC

News

Northrop Grumman awarded a $43.9 million contract by the U.S. Department of Defense for new rocket motor production facilities for the Trident II system.

23 ott 2026, 23:06 UTC

News

Valero Energy Corp shares advanced in after-market trading following a significant increase in third-quarter net income and revenue amid rising oil prices.

23 ott 2026, 23:01 UTC

News

FuelCell Energy Inc. faces a class action lawsuit from Pomerantz LLP alleging securities fraud linked to claims about manufacturing capacity and production rates.

23 ott 2026, 23:01 UTC

News

JetBlue faces negative sentiment as creditors meet with a restructuring adviser amid declining bond and share values, according to The Wall Street Journal.

23 ott 2026, 23:01 UTC

News

Uber is reportedly in talks to acquire Instacart, alongside DoorDash, amid increased interest in food delivery sector acquisitions, contributing to after-market gains.

23 ott 2026, 23:01 UTC

News

DICK'S Sporting Goods faces a class action lawsuit over securities fraud, following earnings of $3.53 per share and revenue of $1.73 billion, both below expectations.

23 ott 2026, 22:56 UTC

News

SS&C Technologies Holdings Inc is trading higher in after-market hours following financial updates that revealed increased revenue, record adjusted EBITDA, and a raised dividend.

23 ott 2026, 22:41 UTC

News

MetroCity Bankshares reports Q3 net income of $24.3 million, up from $22.1 million, but total revenue of $47.942 million misses expectations of $51.300 million.

23 ott 2026, 21:51 UTC

News

General Mills Inc shares rose in after-market trading following the launch of EPIC Sticks, amid broader market gains and positive U.S. business activity indicators.

23 ott 2026, 21:02 UTC

News

Union Pacific Corp's shares declined in after-market trading.

23 ott 2026, 21:02 UTC

News
Correlated Moves

USD/PLN is advancing, supported by a stronger U.S. dollar amid rising crude oil prices and inflation expectations following robust U.S. manufacturing data.

23 ott 2026, 21:02 UTC

News

The USD/DKK is trading higher, supported by stronger U.S. economic indicators, while Eurozone activity shows signs of weakening, with France's output index declining.

23 ott 2026, 21:02 UTC

Correlated Moves
News

USD/CZK is trading modestly higher, supported by U.S. dollar strength amid concerns over weakening Eurozone economic activity and rising inflation expectations.

23 ott 2026, 21:01 UTC

News

Illinois Tool Works Inc. is trading modestly higher in after-market hours ahead of its September quarter results, with expected earnings of $2.99 per share.

23 ott 2026, 20:13 UTC

News

Ensign Group schedules its Q3 2026 earnings call for October 28, following results on October 27, generating investor interest in after-market trading.

23 ott 2026, 20:08 UTC

News

Medpace Holdings Inc received multiple price target increases today, with Mizuho raising its target to $730 and Baird to $699, among others.

Confronto tra pari

Modifica del prezzo

Day One Biopharmaceuticals Inc Previsione

Obiettivo di Prezzo

By TipRanks

-3.62% in calo

Previsioni per 12 mesi

Media 20.75 USD  -3.62%

Alto 21.5 USD

Basso 17 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Day One Biopharmaceuticals Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

7 ratings

1

Acquista

6

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
help-icon Live chat